Sinusoidal Obstruction Syndrome Withdrawn Phase 4 Trials for 1,2-Distearoyllecithin (DB14099)

Also known as: Hepatic Veno-Occlusive Disease / Venoocclusive syndrome of the liver / Venoocclusive liver disease

IndicationStatusPhase
DBCOND0043505 (Sinusoidal Obstruction Syndrome)Withdrawn4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03963999Validating Ultrasound Biomarkers for Hepatic Sinusoidal Obstruction Syndrome in Pediatric Hematopoietic Cell Transplant PatientsDiagnostic